Status:
COMPLETED
The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of high-dose ascorbic acid on microcirculation in sepsis.
Detailed Description
Adult patients with septic shock were enrolled within 24 hours following admission to the Central Department of Intensive Care in Lithuanian University of Health Sciences Hospital Kaunas Clinics. Par...
Eligibility Criteria
Inclusion
- Patients with sepsis or septic shock within the first 24 hours after ICU admission.
Exclusion
- Age \< 18 years,
- Pregnancy,
- Advanced malignancy,
- History of kidney stone, glucose-6-phosphate deficiency, hemochromatosis, or solid organ transplantation,
- Oral mucosal inflammation or injury or technical difficulties in obtaining sublingual images.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04773717
Start Date
January 1 2019
End Date
January 31 2021
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lithuanian University of Health Sciences Hospital Kaunas Clinics
Kaunas, Lithuania